201247265 六、發明說明： 【發明所屬之技術領域】 [0001] 本發明係有關於一種三成分混合裝置 例如用於外科手術或牙科手術(或合2，其 黏接劑的混合容器。 ）寺之一成分混合 【先前技術】 【0002】 例如’在外科手術或牙科手術⑽處理）中， 進行縫合。在該縫合線之縫合中，由於係以合線 ，進行手術’所以無法完全免去感染之風險。而且，在時 留下大範圍的明顯疤痕，因此近年來，在外 在手術後會 有時^縫合線與黏接劑，或單獨使用黏接， 口，便可減少手術時的感染風險，此乃理所接二1用 更加提升手術後的美觀性。 π理所田然’並可 【0003】 柹用^用於外科手術或牙科手術(或處理)等之黏接劑，大多混人 埴#於夂〃以上成分。以往使用此種黏接劑時，係將此等藥南丨預^ 内。而在使用時將第-成分容器與第-成分容ί 兹卸下’將另-方的藥劑移至其中—容^ 兩種藥劑的f亡 情形—般是在混合有 用時將此三成分適量且均勻混合之作業很 [0004] 成分^埴分混合雜狀混合，如補讀1，係預先將二 ΪϋΪί 個注射器内，在使用時對著虹筒按齡塞，藉 器中分離的二成分加以混合，此種裝置很普及。然而 亦有將二成分_舰合之雜劑，實際上人解求—種無論何 201247265 人皆可簡單地進行混合之三成分混合裝置。 [習知技術文獻] [專利文獻] 【0005】 專利文獻1 ··日本特開平7·136264號公報 【發明内容】 [發明所欲.解決的問題] 【0006】 1外科手術例如將用 可簡單一此一等^ 【0007】 使用ίί成«合处齡齡黏接劑 [解決問題之技術手段] 【0008] ϋί成i述目的，本發明之三成分混合裝置，包含. 之間故納有第-藥劑，在樂劑噴出卩與該第-密合墊 苐二藥劑；以及” °x第1、a塾與第二密合塾之間收納有 式安ίί收 動方式插人該注射器、；、、’並可由其前端做可任意滑 成分fί裝置之特徵在於： 並且將該樂劑容器内的該第三藥劑與該注射二二該第二 劑容器内的朝向前端側滑動，藉以使該藥 且將_，丨；ΐ1過該貫通孔而導入該注射器内.； 藥 4 201247265 使二成分相混合的藥劑 劑及該第一藥劑在該注射器内依序混合 通過該藥劑喷出口往外方噴出。 【0009】 、 單地進行三種藥劑之岣句混合。 若為此種構成，便可簡 【0010】 在此，本發明宜為： 於5亥；主射态，分別設有從該注射器 形成之第一旁通溝槽與第二旁通溝槽， 的内表面朝外表面隆出而 該第旁通溝槽-致之位置時，於 —致之位置時，於 虽該第一密合墊移動至與該第一旁通溝槽 該第一密合墊的兩側形成藥劑通路。 【0011】 劑三以及此二成分 的樂劑通路而相混 若為此種構成，便可使第三藥劑與第二藥 為劑與弟一藥劑通過形成於旁通溝槽周^ 合。 【0012】 塞滑動的指觸 再者本發明宜為：該注射器具備有用以使該 凸緣。 【0013】 若為此種構成，便可鮮地進行雜柱絲混合藥劑時之作 【0014】 用的底板構件。 又本發明宜為：該藥液容器具備有防止翻覆 【0015】 若為此種構成，便可將藥液容器保持在自立狀熊。 【0016】 〜 再者本發明宜為：該藥液容器具備有將該藥劑喷出口穿孔之 針構件。 【0017】 201247265 藉由該針構件可穿孔出使藥劑流通的孔洞。. 【0018】 體或本ίΓ:該第—藥劑為粉體或液體，該第二藥劑為液 體細體，該第三㈣I驗體亦可。 【0019】 第：第—藥劑為粉體或液體，第二藥劑為液體或固體， 一 體時，終端使用者可立即將三成分加以混合使用。 成 本發明之二成分混合套件，其特徵在於由以下元件所構 一..... ♦ · 置有侧=劑喷出口，並以可任意滑動方式配 之間收納第:荦劑塾宏喷出口與該第-密合墊 藥劑；以ί 在第 塾與第二密合墊之間收納第 式安裝有收:哭且可任意裝卸方 動方式插人該注射器 並可由其刖端側以可任意滑 【0021】 根據此種三成分混合套件， 即將三成分加以混合使用。P了方便運运’終多而使用者可立 【0022】 體’皆合以或液 卜科手術或牙科手術 I對照先前技術之功效] [0024] ，本發明，便可簡單地進行 哪何人射簡單且均勻地將三成分適量句勻W。又，無 【0025】 201247265 二旁通溝槽射面隆出而形成之第-旁通溝槽與第 -致之位置時，二動至與第-旁通溝槽或第二旁通溝槽 【0026】 ttia。 柱塞ίΪ合;具備了指觸凸緣，便可簡單地進行推壓 【0027】 /、 液容器保持具備有防止翻覆用的底板齡，便可將藥 【0028】 " 洞。再者’若注射器具備有針構件，便可穿孔出使_流通的孔 【0029】 術==術(偷)切使_^=/«外科 【實施方式】 [實施發明之最佳形態】 【0032】 以下說明本發明。 【0033】 <第一實施例> 首先，參照圖1(A)、（B)所示之筮， 【0034】 弟1貫細例來說明本發明。 201247265 制”第Li施^的二成分混合裝置’係騎預先收納有第-藥 钟J130與第二藥劑HO之筒狀注射器1〇〇安妒了於接 二 藥液容器180的柱塞160戶斤構成之裝置。推壓藥二容哭、、⑽ =部而使第三藥劑Π0通過貫通孔15G導人注射器卿喝對 注射器1〇〇按壓柱塞·，藉此將設於柱塞16〇的藥液容界 内之第三藥劑170、與注射器⑽内的苐一藥劑13 °^ 内的第二藥劑140加以混合。 心100 【0035】 亦即，.在本發明第1實施例的三成分混合裝置3⑻中， 狀注射器⑽第-密合塾11G與第二密合墊12()机隔1 隔士收納之，在由其等的藥劑噴出口 171與第一密合墊11〇與 二密合塾120所密封的兩個室n，預先收納有第一藥 ^ 二藥劑140。 ' ”牙 【0036】 另一方面，預先準備於軸方向形成有貫通孔15〇之柱塞本體 160a，在此柱塞本體160a的後端侧裝設收納有第三藥劑17〇 液容器180。藉此構成柱塞160。 八 【0037】 柱塞16〇推入注射H 100内，首先，使藥液容器⑽内 的第三藥劑170導入注射器100内，其次再推壓柱塞16〇，使第二 密合墊120移動至與第二旁通溝槽幻一致之位置。 — 【0038】 菖第一在合墊120移動至與第二旁通溝槽％ —致之位置，便 於^二密合墊12G的周圍形成嶋:，所以此酿成為藥劑通路， 第三藥劑170與第二藥劑140通過此間隙而互相混合。 【0039】 再者，藉由推壓柱塞160 ’使柱塞160抵接在位於與第二旁通 85 —致之位置之第二密合墊12〇。然後，再次推壓使上述第 三藥劑j7〇與第二藥劑14〇相抵接的柱塞16〇，藉此使第二密合塾 12 0隨著第二藥劑14 0與第三藥劑}7 〇的混合藥劑以及第一密合墊 【0040】 201247265 所示’使第一密合塾n。移動至與第- f 1第—密合塾11G移動至與第—旁通溝槽8G —致之位 Ϊ路的，形成間隙’故此間隙成為藥劑 劑在注射器内^和第二樂劑⑽與第三藥劑⑺之混合藥 【0041】201247265 VI. Description of the Invention: [Technical Field of the Invention] [0001] The present invention relates to a three-component mixing device such as a surgical or dental operation (or a hybrid container of adhesives thereof). One-component mixing [Prior Art] [0002] For example, in a surgical or dental surgery (10) treatment, suturing is performed. In the suturing of the suture, since the surgery is performed by the merging, the risk of infection cannot be completely eliminated. Moreover, in the past, a large range of obvious scars are left. Therefore, in recent years, there may be times when sutures and adhesives are used after external surgery, or the adhesives and mouths alone can reduce the risk of infection during surgery. The second one is used to improve the aesthetics after surgery. π理所田然' and [0003] 柹Used for adhesives such as surgery or dental surgery (or treatment), most of them are mixed with 夂〃#. In the past, when such an adhesive was used, it was pre-treated with the drug. In the use, the first-component container and the first-component container are removed, and the other-agent is moved to the inside--there is a case where the two agents are in the form of a mixture. And the operation of uniform mixing is very [0004]. The composition is mixed with mixed impurities, such as the supplementary reading 1. It is pre-filled with two syringes, and the two components separated from the rainbow are used at the time of use. Mixing, such devices are very popular. However, there are also two components _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ [Patent Document] [Patent Document 1] [Patent Document 1] Japanese Patent Application Laid-Open No. Hei 7-136264 [Draft] [0006] [Problems to be Solved by the Invention] [0006] A surgical procedure can be used, for example. One by one ^ [0007] The use of ίί into the "age age bonding agent [technical means to solve the problem] [0008] ϋί成 i the purpose of the three-component mixing device of the present invention, including a first-agent, which is inserted between the agent spray sputum and the first-closed pad; and "°x first, a 塾 and the second 塾 收纳 收纳 收纳 收纳 该 该 该The device can be arbitrarily slidable by its front end, and is characterized in that: the third medicament in the agent container is slid toward the front end side of the injection container and the second agent container, thereby The medicine is introduced into the syringe through the through hole. The medicine 4 201247265 The medicine agent which mixes the two components and the first medicine are sequentially mixed in the syringe through the medicine discharge port to the outside. Squirting. [0009] Sentence mixing. If it is such a composition, it can be simplified [0010] Here, the present invention is preferably: at 5 hai; the main illuminating state, respectively, is provided with a first bypass groove and a second bypass formed from the syringe When the inner surface of the groove is raised toward the outer surface and the position of the first bypass groove is at the position, the first adhesion pad moves to the first bypass groove The drug passage is formed on both sides of the first adhesive pad. [0011] If the agent 3 and the two agent components are mixed, if the composition is such, the third drug and the second drug can be used as the agent and the drug. By the formation of the bypass groove, it is preferable to use the syringe to provide the flange. [0013] If it is such a configuration, it can be performed freshly. When the hybrid column is mixed with a chemical agent, the bottom plate member used for [0014]. The present invention is preferably: the liquid chemical container is provided with a preventive overturning [0015]. If this configuration, the liquid chemical container can be kept in a self-supporting bear. [0016] Further, the present invention is preferably: the liquid medicine container is provided with the medicine discharge port The needle member of the hole. [0017] 201247265 The needle member can perforate a hole through which the drug flows. [0018] The body or the body is a powder or a liquid, and the second agent is a liquid body. The third (four) I test may also be. [0019] The first: the first agent is a powder or a liquid, and the second agent is a liquid or a solid. When integrated, the end user can immediately mix the three components. The two-component mixing kit is characterized in that it is composed of the following components: .... ♦ · There is a side = agent discharge port, and can be stored in an arbitrarily slidable manner: the sputum 塾 macro vent outlet and the first - Closed padding agent; ί Between the second 塾 and the second commissure pad, the first type of installation is received: crying and can be arbitrarily loaded and unloaded to insert the syringe and can be arbitrarily slipped by the 刖 end side [0021 According to this three-component mixing kit, the three components are mixed. P is convenient for transportation, and the user can stand up [0022] The body is combined with the liquid surgery or dental surgery I to compare the efficacy of the prior art] [0024], the present invention, can simply carry out who Shooting simply and evenly mixes the appropriate three-component sentence. Further, when there is no [0025] 201247265, the second bypass to the first bypass groove or the second bypass groove when the second bypass groove surface is formed by the first-bypass groove and the first position. [0026] ttia. Plunger ; ; ; 具备 ; ; ; ; ; ; ; ; ; ; 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 【 Furthermore, if the syringe is provided with a needle member, it can be perforated to make the _ circulation hole [0029] surgery == surgery (stealing) cut _^=/ «surgery [embodiment] [implementing the best form of the invention] The present invention will be described below. <First Embodiment> First, the present invention will be described with reference to Figs. 1(A) and (B). 201247265 The "two-component mixing device of the Li" is a cylindrical syringe 1 in which the first medicine clock J130 and the second medicine HO are stored in advance, and the plunger 160 of the second medicine liquid container 180 is installed. The device consisting of jin. The pushing drug is second, crying, and (10) = the third drug Π0 is passed through the through hole 15G to guide the syringe to drink the syringe 1 〇〇 press the plunger, thereby being placed on the plunger 16〇 The third medicament 170 in the liquid medicine volume is mixed with the second medicament 140 in the syringe (10) within 13 ° of the syringe (10). Heart 100 [0035] That is, in the third embodiment of the present invention In the component mixing device 3 (8), the first syringe 11G and the second gasket 12 are placed in a compartment, and the drug outlet 171 and the first gasket 11 are used. The two chambers n sealed by the second sealing unit 120 are preliminarily stored with the first medicine and the second medicine 140. ' ” teeth [0036] On the other hand, the plunger body 160a having the through holes 15A formed in the axial direction is prepared in advance. A third medicine 17 sputum container 180 is housed in the rear end side of the plunger body 160a. Thereby, the plunger 160 is constructed. [0037] The plunger 16 is pushed into the injection H 100. First, the third medicament 170 in the liquid medicine container (10) is introduced into the syringe 100, and then the plunger 16 is pushed again to move the second adhesion pad 120. To the position that coincides with the second bypass groove. — [0038] 菖 first in the mat 120 to move to the position of the second bypass groove %, to facilitate the formation of 嶋: around the two close mat 12G, so this brewing into a drug passage, the third medicament 170 and the second medicament 140 are mixed with each other through the gap. Further, the plunger 160 is abutted against the second abutment pad 12 at a position corresponding to the second bypass 85 by pushing the plunger 160'. Then, the plunger 16A that abuts the third medicament j7〇 and the second medicament 14〇 is pressed again, whereby the second adhesive 塾120 follows the second medicament 14 0 and the third medicament 77 The mixture and the first adhesive pad [0040] 201247265 are shown as 'making the first seal 塾n. Moving to the first-close contact 塾 11G and moving to the position of the first bypass groove 8G, forming a gap, so the gap becomes a medicament in the syringe and the second agent (10) a mixture of the third agent (7) [0041]
成分混合裝置，係將混合有該三成分的荜劑 攸刖端側的樂劑喷出口 171排出之裝置。 又刀町术片J 【0042】 一 〈第2實施例> 以下說明本發明的第2實施例。 【0043】 ' 亦能^以一構件構成了注射器100的筒體，但 丌月b以一構件以上來構成注射器1〇〇的筒體。 丨 如圖2[0=所示，係以二構件來構成注射器A的筒體 30 第-構件1之-部分剖面^與其俯視f 所显貞干1为丨® iSl , dl弟一構件本歧兩端部分別將蓋部取下 不之。〗關’ gj 4(B)係圖4(A)所示第 別裝上了蓋部時之剖面圖。 ④雜之本體兩女而。P刀 【0045】 第2實施例的三成分混合裝置3〇 置而有各種用途’但在以下m J马用U二成/刀的裝 例來說額絲接劑的混合^裝置。二成分所構成的藥劑為 【0046】 ° 在圖2所7Γ之第2貝施例之三成分混合展置如中，藉由圖3(a) 201247265 所示之第一構件1，與圖4(A)所示之第二構件7之二構件，構成 了注射器A。在此第二構件7 ’可任意滑動地裝設在第一構件工 内。 【0047】 又二成分混合裝置30，係由由第一構件〗與第二構件7所構 成的注射器A(圖7)，以及在柱塞本體23a上組合有藥液容哭2〇 的容器本體20a(圖8)之柱塞B所構成。 ° 【0048】 第一構件1與第二構件7與柱塞本體23a與容器本體 -由透明構件所構成.以便可確認内部的 。 【0049】 側開筚$本體1a形成為略成筒狀’於前端 藥劑噴出口 2的^圍戶另一方面’在圍繞本體la的 2c〇 ^騎W德塞部2b之_ ©，形成有内螺紋 【0050】 用以密封該藥劑t =3之前端侧5設之藥劑噴出口 2， 刷構件4係分別選擇性地且任音劑^出^ 2連通之毛 端閉塞，故藥劑等不會從此蓋‘ ^ H，讀3由於前 ° 3 二的=:時’無法進行本體la 確保空氣觀。.，賴絲體3略為鬆緩來 【0052】 二严邊額互㈣向的位置 2個，在第，-本 201247265 即可。第-構件1的本體la之基端部，具有指觸凸緣6。此指 凸緣6亦可以別的構件所構成，亦可一體形成。在將第—構^ 與第二構件7組裝，將蓋體3安裝在第一構件丨的栓塞部孔 便構成圖7所示之注射器a。 【0053】 第二構件7，如圖4(A)所示，係在其本體7a的轴方向之内周 面相離既定間隔，使第一旁通溝槽1〇與第二旁通溝槽η朝外側 隆出而形成。而在第二構件7的本體％内，第一密合墊g與第二 密合墊9係隔著第二旁通溝槽η所裝設。第一密合墊8與^二^ •合墊9係由橡膠_、合成樹脂等所形成。又，藉由橡膠栓及鋁 蓋12b來防止第一藥劑15第二藥劑17的洩漏。最外方的蓋部i2c 雖亦可為金屬製，但在本實施例中，係由合成樹脂所形成。 【0054】 a ±當第一密合墊8與第二密合墊9係隔著第二旁通溝槽11所裝 設時，第一腔室14在橡膠栓12a與第一密合墊8之間、第二腔^ 16在第密合墊8與第二密合墊9之間、第三腔室18在第二密合 墊9與蓋部13之間分別構成。而在第一腔室14與第二腔室16内 預先收納第一藥劑15與第二藥劑17。 【0055】 又柱塞本體23a ’如圖5(A)所示，在後端部23c與前端部23b 之間，徑為相異。又，於柱塞本體23a，橫跨其兩端部形成有貫通 孔19j再者，於柱塞本體23a的後端部23c與前端部23b，分別 具有密封部22b、22a。此等密封部22a、22b ,亦可盥柱塞本體23a 一體形成，亦可各自形成。 【0056】 又，如圖5(B)所示之柱塞本體23a，，令徑為相同，於其途中 使握持用環33a、33a以既定距離相離設置亦可。 【0057】 —如此设置握持用環33a、33a，便可簡單地進行對圖6所示之 容器本體20a推壓柱塞本體23a，時之作業。 201247265 【0058】 柱塞本體23a、23a’，雖輯絲接綱_之麵而显，但 一般宜由具耐藥性的聚丙烯樹脂等所形成。 /、 一 【0059】 如？ 6所示，收納第三藥劑21的藥液容器2〇，係由容器本體 於所構成。又，於蓋體2〇b裝有橡膠栓20c，於橡膠 有樹脂製薄膜，較佳為_旨薄膜t 生的玻璃卿成。此種藥液容器取裝設 於柱塞本體23a而構成如圖8所示之柱夷B。 【0060】 .…-… " 底板’紗、設有底面形成為大徑之略成凸狀的 ίf器本體20a裝設底板構件24 ’便可防止容 20aR/换b!。在出貪時，將第三藥劑21收納於此容器本體 Hi橡膝检20c的蓋體2〇b裝設在容器本體2〇a ° 成：分混合裝置，在制前由注射11 A與柱塞B構 在朗時則純組裝來使用。 劑之ί貫施例的三成分混合裝置3。姆療用的黏接 【0063】 理)的合I置^係用於外科手術或牙科手術(或處 為觸媒/二^15為聚合物(健），第二藥劑17 _的粉W 體 可舉出由甲基丙烯酸®旨共聚物所 烯酯共聚物所構成的粉體。 其部分氧化^代體）’可舉出例如三絲硼或 於例如非質子之合物、以及將有_化合物溶解 /媒、或非質子性溶媒中混合了少量醇之混合溶 12 201247265 媒等溶媒之液體。 【0065】 再者，成為第三藥劑21的單聚物(液轉彳 烯酸甲醋、4_甲基丙烯喊乙基偏苯三例如曱基丙 酯及丙烯酸酯。 针為代表的甲基丙烯酸 【0066】 的第有二成分 Γ:12c取下時，上The component mixing device is a device that discharges the agent discharge port 171 on the side of the crotch of the three components. Kakushomachi J [0042] I. <Second Embodiment> A second embodiment of the present invention will be described below. [0043] 'The barrel of the syringe 100 can also be constructed by one member, but the barrel of the syringe 1 is constituted by one or more members.丨As shown in Fig. 2 [0=, the cylinder 30 of the syringe A is composed of two members, the section of the first member 1 and the top view thereof are shown as the f® iSl, dl The cover portions are removed from the ends. 〖Off' gj 4(B) is a cross-sectional view of the case where the lid portion is attached as shown in Fig. 4(A). 4 mixed body and two women. P-knife [0045] The three-component mixing device 3 of the second embodiment has various uses, but the following is a mixing device for the front-end bonding agent in the following U. The agent composed of the two components is [0046] ° in the second component of the second embodiment of Fig. 2, as shown in Fig. 3, the first member 1 shown in Fig. 3 (a) 201247265, and Fig. 4 The two members of the second member 7 shown in (A) constitute the syringe A. Here, the second member 7' is slidably mounted in the first member. [0047] The second component mixing device 30 is composed of a syringe A (FIG. 7) composed of a first member and a second member 7, and a container body in which a liquid medicine is mixed on the plunger body 23a. The plunger B of 20a (Fig. 8) is constructed. [0048] The first member 1 and the second member 7 and the plunger body 23a and the container body are composed of a transparent member so that the inside can be confirmed. [0049] The side opening 本体 $ body 1a is formed in a slightly cylindrical shape 'at the front end of the medicine discharge port 2 on the other hand', on the other hand, around the body 2a 〇 ^ ride W Desai part 2b _, formed with Internal thread [0050] For sealing the medicament outlet 2 provided on the front end side 5 of the medicament t=3, the brush member 4 is selectively occluded by the hair ends of the communication agent 2, so the medicine or the like is not Will cover from this ^ ^ H, read 3 due to the former ° 3 two =: when 'can not carry out the body la to ensure the air view. ., the body of Lai body 3 is slightly loose. [0052] The position of the two sides of the two sides is four, in the first, - 201247265. The base end portion of the body la of the first member 1 has a finger touch flange 6. The flange 6 can also be formed by other members or integrally formed. The syringe a is shown in Fig. 7 by assembling the first member and the second member 7, and attaching the lid 3 to the plug portion of the first member. [0053] The second member 7, as shown in FIG. 4(A), is spaced apart from the inner circumferential surface of the body 7a by a predetermined interval, so that the first bypass groove 1〇 and the second bypass groove η It is formed by bulging outward. In the body % of the second member 7, the first adhesion pad g and the second adhesion pad 9 are disposed via the second bypass groove η. The first adhesive pad 8 and the second bonding pad 9 are formed of rubber _, synthetic resin or the like. Further, leakage of the second medicament 17 of the first medicament 15 is prevented by the rubber stopper and the aluminum lid 12b. The outermost cover portion i2c may be made of metal, but in the present embodiment, it is formed of a synthetic resin. [0054] a When the first adhesive pad 8 and the second adhesive pad 9 are mounted via the second bypass groove 11, the first chamber 14 is in the rubber plug 12a and the first adhesive pad 8 The second chamber 16 is formed between the first adhesion pad 8 and the second adhesion pad 9 and the third chamber 18 is formed between the second adhesion pad 9 and the lid portion 13, respectively. The first medicament 15 and the second medicament 17 are preliminarily accommodated in the first chamber 14 and the second chamber 16. Further, as shown in Fig. 5(A), the plunger main body 23a' has a different diameter between the rear end portion 23c and the front end portion 23b. Further, in the plunger main body 23a, a through hole 19j is formed across the both end portions thereof, and the rear end portion 23c and the front end portion 23b of the plunger main body 23a have sealing portions 22b and 22a, respectively. The sealing portions 22a and 22b may be integrally formed with the plunger body 23a or may be formed separately. Further, as shown in Fig. 5(B), the plunger main body 23a has the same diameter, and the grip rings 33a and 33a may be disposed apart from each other at a predetermined distance. When the grip rings 33a and 33a are provided in this manner, the operation of pressing the plunger body 23a to the container body 20a shown in Fig. 6 can be easily performed. 201247265 [0058] The plunger bodies 23a and 23a' are formed by the surface of the wire, but are generally formed of a polypropylene resin having resistance. /, a [0059] Such as? As shown in Fig. 6, the chemical solution container 2 that houses the third drug 21 is constituted by the container body. Further, a rubber plug 20c is attached to the lid body 2b, and a resin film is formed on the rubber, and it is preferable that the film is made of glass. This liquid medicine container is attached to the plunger body 23a to form a column B as shown in Fig. 8. [0060] ....-... " The bottom plate' yarn, and the bottom plate member 24' provided with the substantially sturdy slab body 20a formed with a large diameter on the bottom surface can prevent the capacitance 20aR/change b!. In the case of greed, the third medicament 21 is housed in the lid body of the container body Hi rubber knee test 20c. The lid body 2〇b is installed in the container body 2〇a° into a sub-mixing device, and the injection is 11 A and the column before the preparation. The plug B structure is purely assembled for use in Langshi. A three-component mixing device 3 of the embodiment. The bonding of the medical treatment is used for surgery or dental surgery (or for the catalyst / two 15 for the polymer (jian), the second medicament for the 17 _ powder W body A powder composed of a methacrylic acid-based copolymer olefinic ester copolymer may be mentioned. The partially oxidized compound thereof may, for example, be a tri-silica or a compound such as an aprotic, and A compound dissolved in a medium or an aprotic solvent is mixed with a small amount of a mixture of alcohols and a liquid such as a solvent such as 201247265. Further, it is a monomer of the third drug 21 (liquid to decenoic acid methyl vinegar, 4-methacrylic acid ethyl benzene benzene such as mercaptopropyl acrylate and acrylate. The second component of acrylic [0066]: when 12c is removed, the upper
蓋中央财孔洞者。又，^下巧使用-開始_ 【0067】 J 件7 itm3 ί設於第-構件1的前端側之後，將第二構 外方的签/ίΐ1内。此時’使隆出於第二構件7的本體％之 2的弟—旁财槽1G、第二旁輸t η與第-構件^籌槽 1 【0068】 A f ^構件7，如圖7所示，構成注射器 將蓋體3猶t緩。為了進行抽氣’宜如圖9所示預先 【_】 內，二射+器A之後，將第二構件7更推人第一構件1 八藥蚓自為藥劑噴出口 2a所貫通。藉此，形成藥劑及混 合樂劑自㈣噴出口 2流出的孔洞。 【0070】 "λ 構成注射器A’另-方面，㈤圖6所示將蓋體施 5收二Ϊΐ二藥齊j21 #藥液容器20a本體取下，將柱塞本體23a 壓入二二體20a。藉此構成圖8所示之柱塞B。 如此為之而構成注射器A與柱塞B，便可完成三成分混合作 13 201247265 業的準備。 【0072】 以下說明混合作業。 【0073】 圖12中’以大略時序顯示混合順序。 3〇之圖圖1〇(Α)係顯示將杈塞Β裝設在注射器Α的三成分混合裳置 【0075】 _鬆缓。從圖障)的姿態中所體3 於注射器A移動，朝箭頭F古a㈣〜气f塞本體23a保持不相對 使柱塞本體23a保持不相對體挪的底部，如此’ 20a的庙邱子於'主射裔A移動，而先推壓容器本體 /主射裔A内的第三腔室18内。 守八 【0076】 其結果，如圖10(B)。 【0077】 進而tmt21導人了注射器a内的第三腔室μ内後， 3 f「推壓柱塞β的容器本體施的底部。於是第三 = 漸升高’因而從圖丨。⑹的狀態變為圖“ 【0078】 亦即，第二密合墊9往藥劑嘖屮 合塾9往筚射+ σ 2 ，2側移動。如此，第二密 μ π ―岛片喷出側移動’苐二密合塾9到達與第二旁通溝 ^位詈U立置。若第二密合塾9到達與第二旁通溝槽11 一致 ]第二密合塾9變得無法在此位置鑛。此時，在第二 周圍形成間隙，成為藥劑通路。因此，第三腔室18與 至6之間，係通過形成於第二密合塾9周圍的間隙而相連 14 201247265 通 【0079】 因此，第二腔室16内的第2藥南 的第三藥劑21，如圖ιι(Α)所示係^人），14從柱塞B送來 【0080】 ° 若從此狀態、中，再將柱塞B朝向 圖_所示，以柱塞B的前端側推/第^出/ 2側^入，， 内的内壓上升，第一密合墊8隨之移 。墊，第一腔至16 【0081】 ° 其結果’第一密合墊8到達與第—套 於是第-密合墊8變得無法在此位m〇 一致之位置。 周圍形成間隙，成為藥劑通路。因此動而6在U合塾8的 之間成為連通狀態。 弟—I至16與第一腔室14 【0082】 因此，收納於第一腔室14内的第j M 二藥劑17與第三藥劑21合 ^^和先刖混合的第 【0083】 ％ U’在腔室U内互相混合。 最後如圖11 (C)所示，=成分相、.日人如 2的蓋體3確_。秘合將 震動=】2。秒左右’便可使三成分約略均勻地向激烈 的成f的混合完成。而最後’將安裝於藥劑喷出口 2 便完成使用前的準備 。：：JJO. 3 【0085】 -(B) 【0086】 201247265 如此，第2貫施例的二成分混合裝置3〇 ,由於在一次的混合 中使既定量彼此混合’故可得到所需之強度。又，在使用大量的 劑時，藉由增加2根、3根三成分混合裝棄3〇，而可得到既 定1。 【0087】 _ Ϊ丄雖說明了在第2實施例中第-藥劑15為粉體之情形，但 „此第-藥劑15在内’所有藥劑均為液體，亦可進行混合。 又’第2藥劑並不限於液體，亦可為固體。 【0088】 料第2實施例中’有關第―構件1〜柱塞本體说等構成- ίίΖί。’雖無特別論及’但宜對應所使用的藥劑以適當的材 【0089] 可適ίί 或如)帽朗軸接劑外， 【0090] 藥劑=====收”三 樂劑=】_卸，並枝二I二 體26將橡膠栓1 ，首先對著容器本 次，如圖13⑼所示使链蓋' 6fpf盘山27坎合於容器本體26，其 蓋27安裝在容器本體26亦可。亦歼即口端亦面^内j則曲折’藉此將鋁 蓋體以捲封方式安裝在容Ϊ本體^。，亦可將由銘蓋27所構成的 【0092】 大地形成。林體％上未形成螺紋牙，_端部的徑稍微粗 【0093】 另，於紹蓋27的外方裝設有未 口不的塑膠盍。將此塑膠蓋卸 16 201247265 下後，可將鋁蓋27與橡膠栓28—併卸下。 【0094】 又’在橡膠栓28的底面，宜預先介右古— 之氟樹脂薄膜29。 、 有鐵氟瀘(註冊商標等) 【0095】 容^上毛刷構件的喷出部32之前端面傾斜地形成，便可 【0096】 另，在圖14中毛刷構件4S係以標準形顯示。 【097】·..···. 另【二】面’毛刷構件4S，’其喷出部32係傾斜既定角度。 傾斜礼’、伙亦與毛刷構件4S，相同，其_ ^係 【0099】 又，毛刷構件4L、4L，，在圖14中，係以七l 傾斜=^斜形成，此等上 又’毛刷構件4R、4R’，在圖14 Φ，及、 右上傾钭的方彳顧私# 士 係以另一方的端部往 ^爾的梅麟軸，此_毛_件4R、视，適合右手使 【0101】 如此，配合使用者的慣用手來選擇毛刷 岛 使用便利性變得良好。又，在 Μ ⑽斜角度’則 亦可使用管狀喷嘴4Α。 接斷，如圖15所示， [0102] <第3實施例> · 圖16〜圖17顯示本發明的第3實施例 中所採用的注射器D。 口 b 4不弟3只施例 【_3】 17 201247265 此第3實施例中，就注射器而言，不同於第i實施例及第2 貫加例之處如下.注射态本體的藥劑章出口所形成的略成筒狀的 外側前端部係以另一構件形成；以及指觸凸緣係以不同於注射哭 本體的構件形成。 °° 【0104】 其他與第2實施例相比並無重大變更，故在同一要素上附上 同一符號以省略詳細說明。 【0105】 如圖16所示’此注射器D，係在筒狀的注射器本體術相離 既定間隔縣·絲-旁通触1G絲二料雜14。而在 * ’ ΐ 一密合塾8與第4合塾9係配置成可滑動。再者，亦i 第2貫施例相同，於栓塞部2b裝設有橡膠检12 【0106】 ^ 另一方面，在第3實施例的注射器D中，注射哭 藥劑嘴出口 2所形成的略成筒狀的外側前端部知係以另一構件j 成。，丄指觸凸緣6係以不同於注射器本體％ :。 而此外側前端部50在使用於注射器本體7G ^成 【0107】 泡坎〇 此外側前端部50,相當於圖3所示之第 〇 5〇 " ^ 【0108】 藉由將此種外側前端部5〇裝設在 膠栓12a開孔。 ①益不7〇a ’而可在橡 【0109】 在此，雖然圖3所示之蓋體3未於車 可採用於軸方向預先形成貫通孔= 使海绵之類的多孔質性的縣構件介在^便可 任意進行減。採肢種蓋體，便射，因而可 作業。 尤专為了柚氣所進行的鬆缓 18 201247265 【0110】Cover the central financial hole. Further, the following is the use of the first component of the first member 1 after the front end side of the first member 1 is set. At this time, the younger one of the body 2 of the second member 7 is the side of the body, the second side of the money 1G, the second side of the t η and the first part of the unit 1 [0068] A f ^ member 7, as shown in Fig. 7. As shown, the construction of the syringe will slow the lid 3. In order to perform the evacuation, it is preferable to advance the second member 7 to the first member 1 after the second injection device A, as shown in Fig. 9, before the second injection device A. Thereby, the holes from which the drug and the mixed agent flow out from the (four) discharge port 2 are formed. [0070] "λ constitutes the syringe A' in another aspect, (5) as shown in Fig. 6, the cover body is applied to receive the second and second medicines, and the body of the liquid medicine container 20a is removed, and the plunger body 23a is pressed into the second body. 20a. Thereby, the plunger B shown in Fig. 8 is constructed. In this way, the syringe A and the plunger B are formed, and the three-component mixing can be completed. [0072] The mixing operation will be described below. [0073] In Fig. 12, the mixing order is shown in a rough timing. Figure 3〇(Α) shows the three-component mixed dressing of the sputum in the syringe 【 [0075] _ loose. In the posture of the figure barrier, the body 3 is moved by the syringe A, and the arrow F ancient a (four) ~ gas f plug body 23a is kept at a bottom that does not hold the plunger body 23a relative to the body, so that the temple of the 20a is 'The main shooter A moves, and first pushes the inside of the third body 18 within the container body/main camera A. Shouba [0076] The result is shown in Figure 10(B). [0077] Further, after tmt21 leads the inside of the third chamber μ in the syringe a, 3f "presses the bottom of the container body of the plunger β. Then the third = gradually rises" and thus from Fig. (6) The state changes to the figure " [0078] That is, the second adhesive pad 9 moves toward the drug 塾9 to the + σ 2 , 2 side. Thus, the second dense μ π - island ejection side movement '苐 2 塾 到达 9 arrives at the second bypass groove 詈 U. If the second close contact 9 reaches the second bypass groove 11, the second close contact 9 becomes unable to mine at this position. At this time, a gap is formed around the second portion to become a drug passage. Therefore, the third chambers 18 and 6 are connected by a gap formed around the second close-fitting 14 9 201247265. [0079] Therefore, the second medicine in the second chamber 16 is the third. Drug 21, as shown in ιι (Α), 14 is sent from the plunger B [0080] ° From this state, and then the plunger B is oriented as shown in Figure _, with the front end of the plunger B When the side push/the second exit/2 side is pushed in, the internal pressure rises, and the first adhesive pad 8 moves accordingly. Pad, first cavity to 16 [0081] ° As a result, the first adhesive pad 8 reaches the position where the first-closed pad 8 becomes unable to coincide at this position. A gap is formed around it to become a drug passage. Therefore, the movement 6 is in a connected state between the U and the 塾8. The first to the first chambers 14 to the first chambers 'Mixed together in the chamber U. Finally, as shown in Fig. 11(C), the = component phase, the Japanese person's cover 3 is _. The secret will be vibration =] 2. Around two seconds, the three components can be approximately uniformly mixed into the intense f. Finally, it will be installed at the drug discharge port 2 to complete the preparation before use. ::JJO. 3 [0085] - (B) [0086] 201247265 In this way, the two-component mixing device of the second embodiment has a desired strength by mixing a predetermined amount in one mixing. . Further, when a large amount of the agent is used, a predetermined one can be obtained by adding two or three three-component mixtures and discarding 3 turns. [0087] Although the first drug 15 is in the form of a powder in the second embodiment, the first drug 15 is liquid and can be mixed. The drug is not limited to a liquid, and may be a solid. [0088] In the second embodiment, the first member 1 to the plunger body are configured to be - ίίΖί. 'Although there is no particular mention, 'but it is suitable for the agent to be used. Appropriate material [0089] can be suitable for ίί or such as 帽朗轴接剂, [0090] 药=====收收三乐剂=】_Unloading, and branch II I two body 26 rubber plug 1 First, facing the container this time, as shown in Fig. 13 (9), the chain cover '6fpf panshan 27 is fitted to the container body 26, and the lid 27 is attached to the container body 26. Also, the mouth is also covered, and the inside j is bent. The aluminum cover is attached to the body of the container in a roll-up manner. It is also possible to form the earth [0092] composed of the cover 27. The thread body is not formed on the forest body, and the diameter of the _ end is slightly thick. [0093] In addition, the outer side of the Yushao cover 27 is provided with a plastic plaque. After the plastic cover is unloaded 16 201247265, the aluminum cover 27 and the rubber plug 28 can be removed. Further, in the bottom surface of the rubber stopper 28, it is preferable to introduce the fluororesin film 29 in advance. Teflon (registered trademark, etc.) [0095] The front end surface of the discharge portion 32 of the upper brush member is formed obliquely, and the brush member 4S is displayed in a standard shape in Fig. 14 . [097]·..···. Another [two] surface 'brush member 4S,' the discharge portion 32 is inclined at a predetermined angle. The slanting ceremony ', the gang is also the same as the brush member 4S, the _ ^ system [0099] Moreover, the brush members 4L, 4L, in Fig. 14, are formed by a tilt of seven l = ^, which is again 'Brushing members 4R, 4R', in Fig. 14 Φ, and, on the right, the 彳 彳 彳 彳 # # # # # # 士 士 士 士 士 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 另一 ^ ^ ^ ^ ^ ^ ^ ^ It is suitable for the right hand to make [0101]. The convenience of using the user's dominant hand to select the brush island becomes good. Further, a tubular nozzle 4 亦可 can also be used at the Μ (10) oblique angle ′. The disconnection is as shown in Fig. 15. [0102] <Third Embodiment> Figs. 16 to 17 show a syringe D used in the third embodiment of the present invention. Port b 4 is not the third embodiment [_3] 17 201247265 In the third embodiment, the syringe is different from the i-th embodiment and the second embodiment as follows. The formed cylindrical outer front end portion is formed with another member; and the finger touch flange is formed with a member different from the injection crying body. [0104] Others are not substantially changed from the second embodiment, and the same reference numerals will be given to the same elements to omit detailed description. [0105] As shown in Fig. 16, the syringe D is attached to the cylindrical syringe body at a predetermined interval of the county-wire-bypass contact 1G wire. On the other hand, the * ’ ΐ 密 8 and the 4th 塾 9 are arranged to be slidable. Further, in the second embodiment, the rubber portion 12 is attached to the plug portion 2b. On the other hand, in the syringe D of the third embodiment, the injection of the crying nozzle outlet 2 is formed. The outer front end portion of the cylindrical shape is known to be formed by another member j. , 丄 finger contact flange 6 is different from syringe body % :. The outer front end portion 50 is used in the syringe body 7G to form the outer front end portion 50, which corresponds to the fifth end shown in FIG. 3, and the outer front end is The part 5 is installed in the opening of the rubber plug 12a. 1 benefits not 7〇a ' but can be in the rubber [0109] Here, although the cover body 3 shown in Fig. 3 is not used in the vehicle, the through hole can be formed in the axial direction in advance; the porous member such as a sponge Can be arbitrarily reduced by ^. The limbs are covered with a body and fired, so they can work. Especially for the pomelo gas, the relaxation 18 201247265 [0110]
亦可使用如上述形成的注射器D 圖17所示之三成分混合裝置9G。取纽I A而可構成 【0111】 在—成刀》t匕合裳置90中，胳知：金 如同第2實施例之情形，首先將第_ ^推入注射器D側，便可 腔室18内，1姐H i广樂劑21導人注射器D的第： 藥劑15混合在此混合藥劑中 樂^17 :合，進而將第一 心均勾此合凡成後，將毛刷構件 风广勾 行三成分混合藥劑之塗布。 上以取代蓋體3，便可進 【0112】 - 若疋此種第3實施例之三成分混人 實施例，故組裝作業性良好乃是 【0113] 另，在本發明中，柱塞、注 。、+ 要素的材質’可對應所使用的藥劑^ 、或蓋部等各構成 述實施例所揭示的材料而有任何限〜。、的材料，並不因上 [產業上利用性] 疋 【0114] 本發明，雖可適合用於外科 的黏接劑之混合’但進而亦 ^ ^術(或處理)時所使用 品的黏接劑。 彳种材料的黏接劑或工業製 【圖式簡單說明] 【0031】 圖1(A)、(B)係說明本發明概 ^ 置之剖面®。 、# I侧之三成分混合裝. 圖2係顯示依本發明第 態之前姻。 成分混合裝置組賴狀 201247265 用的二射(器^二=务明第2實施例的三成分混合裝置中所採 第一構件之俯視圖 部分剖面圖；圖3(B)_ 3㈧所示之 本體發明第_2實施例的注射 器之第二構件之 示第二構件之本體兩端，卩;關；圖4_圖4(Α)所 圖邛刀別裝上了蓋部時之剖面圖。 圖5⑻為其變形例。明第2實施例中所採用的柱寨本體之前視圖， 圖。圖6係本發明第2實施例中所採用的藥液容器之一部分剖面 的柱發明第2實施例’由藥液容器與柱塞本體所構成 概略Γ係說本翻第2實施例之三成分混合裝置之組裝之 圖：上面圖。 混合藥劑和第一藥劑相混合'三成分相混合= 係顯示三成分混合裝置的使職II之前侧。目’圖12⑻ 圖13(A)係取代圖6所示藥液容器之其他 ’圖13(B)係以捲封方式組裝紹蓋後的藥液容解剖面 圖14係顯示圖12所示之毛刷構件的各勸二面圖。 圖I5係取代毛刷構件的管狀喷嘴之側視圖。 Ξ;; ίϊίί:第3實施例之注射器之刮面圖。 圖係第3只她例的三成分混合裝置之剖面圖。 201247265 【主要元件符號說明】 【0115】 1〜第一構件 la〜第一構件的本體 lb〜内部空間 2〜藥劑喷出口 2a〜針部 2b〜栓塞部 2c〜内螺紋 3〜.盘體….. 4、4S、4S,、4L、4L，、4R、4R，〜毛刷構件 4A〜管狀喷嘴 5〜溝槽 6〜指觸凸緣 7〜第二構件 7a〜第二構件的本體 8〜第一密合塾 9〜第二密合墊 10〜第一旁通溝槽 11〜第二旁通溝槽 12a〜橡膠栓 12b〜鋁蓋 12c〜蓋部 13〜蓋部 14〜第一腔室 15〜第一藥劑 16〜第二腔室 17〜第二藥劑、 18〜第三腔室 19〜貫通孔 21 201247265 20〜藥液容器 20a〜容器本體 20b〜蓋體 20c〜橡膠栓 21〜第三藥劑 22a、22b~密封部 23a、23a’〜柱塞本體 23b〜前端部 23c〜後端部 •24〜底板構件 25〜藥液容器 26〜容器本體 27〜鋁蓋 28〜橡膠栓 29〜氟樹脂薄膜 30〜三成分混合裝置 32〜噴出部 33a〜握持用環 50〜外側前端部 70a〜注射器本體 80〜第一旁通溝槽 85〜第二旁通溝槽 90〜三成分混合裝置 100〜注射器 110〜第一密合墊 120〜第二密合墊 130〜第一藥劑 140〜第二藥劑 150〜貫通孔 160〜柱塞 201247265 160a〜柱塞本體 170〜第三藥劑 171〜藥劑喷出口 180〜藥劑容器 300〜三成分混合裝置 A〜注射器 B〜柱塞 D〜注射器It is also possible to use the three-component mixing device 9G shown in Fig. 17 of the syringe D formed as described above. Take the New IA to form [0111] In the "Make the knife" t 匕 裳 置 90 90, know: gold as in the case of the second embodiment, first push the _ ^ into the syringe D side, the chamber 18 Inside, 1 sister H i Guangle agent 21 lead syringe D: The medicine 15 is mixed in this mixed medicine, music ^17: combined, and then the first heart is hooked together, the brush member is wide Hook the coating of the three-component mixture. In the present invention, the plunger and the bet are used in the present invention. . The material of the + element may be limited to any of the materials disclosed in the examples, such as the drug to be used or the lid portion. Material, not because of [industrial use] 疋 [0114] The present invention, although suitable for the mixing of surgical adhesives, but also the use of the product (or treatment) Ingredients. Adhesives or industrial systems for various materials [Simplified description of the drawings] [0031] Figures 1(A) and (B) are cross-sectional views of the present invention. The three components of the # I side are mixed. Fig. 2 shows the marriage according to the first aspect of the present invention. In the component mixing device group 201247265, the second component is used in the three-component mixing device of the second embodiment, and the first component is a cross-sectional view of the first component; FIG. 3(B)_3(8) The second member of the second embodiment of the second embodiment of the syringe of the second embodiment of the invention is shown in Fig. 4 to Fig. 4 (Α), and the sectional view of the blade is attached. 5(8) is a modified example thereof. The front view of the pillar body used in the second embodiment is shown in Fig. 6. Fig. 6 is a second embodiment of a column section of a liquid chemical container used in the second embodiment of the present invention. The assembly of the chemical solution container and the plunger body is a schematic view of the assembly of the three-component mixing device of the second embodiment: the above figure. The mixed drug and the first drug are mixed. The front side of the component II of the component mixing device. Fig. 12(8) Fig. 13(A) is the other part of the liquid medicine container shown in Fig. 6. Fig. 13(B) is the anatomy of the drug solution after the capping method is assembled. Figure 14 is a view showing the perforation of the brush member shown in Figure 12. Figure I5 is a tube replacing the brush member. Side view of the nozzle. Ξ;; ίϊίί: Scratch diagram of the syringe of the third embodiment. Fig. 3 is a sectional view of the third component mixing device of the third example. 201247265 [Description of main components] [0115] 1~ The main body 1b to the inner space 2 to the medicine discharge port 2a to the needle portion 2b to the plug portion 2c to the internal thread 3 to the disk body..... 4, 4S, 4S, 4L, 4L, 4R, 4R, ~ brush member 4A - tubular nozzle 5 - groove 6 - finger contact flange 7 - second member 7a - second member body 8 - first close 塾 9 - second close pad 10 ~ First bypass groove 11 to second bypass groove 12a to rubber plug 12b to aluminum cover 12c to cover portion 13 to cover portion 14 to first chamber 15 to first medicament 16 to second chamber 17 to Two medicaments, 18 to third chambers 19 to through holes 21 201247265 20 to the chemical solution container 20a to the container body 20b to the lid body 20c to the rubber plugs 21 to the third medicaments 22a and 22b to the sealing portions 23a, 23a' to the plunger Main body 23b to front end portion 23c to rear end portion 24 to bottom plate member 25 to chemical liquid container 26 to container main body 27 to aluminum cover 28 to rubber stopper 29 to fluororesin Film 30 to three-component mixing device 32 to discharge portion 33a to holding ring 50 to outer end portion 70a to syringe body 80 to first bypass groove 85 to second bypass groove 90 to three-component mixing device 100 to The syringe 110 to the first adhesion pad 120 to the second adhesion pad 130 to the first medicine 140 to the second medicine 150 to the through hole 160 to the plunger 201247265 160a to the plunger body 170 to the third medicine 171 to the medicine discharge port 180 ~ Pharmaceutical container 300 ~ three component mixing device A ~ syringe B ~ plunger D ~ syringe